...
首页> 外文期刊>Frontiers in Cellular Neuroscience >tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations
【24h】

tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations

机译:小鼠tPA缺乏导致脑血管树和脑室畸形的重排

获取原文
           

摘要

The serine protease tissue-type plasminogen activator (tPA) is used as a thrombolytic agent in the management of ischemic stroke, but concerns for hemorrhagic conversion greatly limits the number of patients that receive this treatment. It has been suggested that the bleeding complications associated with thrombolytic tPA may be due to unanticipated roles of tPA in the brain. Recent work has suggested tPA regulation of neurovascular barrier integrity, mediated via platelet derived growth factor (PDGF)-C/PDGF receptor-α (PDGFRα) signaling, as a possible molecular mechanism affecting the outcome of stroke. To better understand the role of tPA in neurovascular regulation we conducted a detailed analysis of the cerebrovasculature in brains from adult tPA deficient ( tPA~(?/?) ) mice. Our analysis demonstrates that life-long deficiency of tPA is associated with rearrangements in the cerebrovascular tree, including a reduction in the number of vascular smooth-muscle cell covered, large diameter, vessels and a decrease in vessel-associated PDGFRα expression as compared to wild-type (WT) littermate controls. In addition, we found that ablation of tPA results in an increased number of ERG-positive endothelial cells and increased junctional localization of the tight junction protein ZO1. This is intriguing since ERG is an endothelial transcription factor implicated in regulation of vascular integrity. Based on these results, we propose that the protection of barrier properties seen utilizing these tPA ~(?/?)mice might be due, at least in part, to these cerebrovascular rearrangements. In addition, we found that tPA ~(?/?)mice displayed mild cerebral ventricular malformations, a feature previously associated with ablation of PDGF-C, thereby providing an in vivo link between tPA and PDGF signaling in central nervous system (CNS) development. Taken together, the data presented here will advance our understanding of the role of tPA within the CNS and in regulation of cerebrovascular permeability.
机译:丝氨酸蛋白酶组织型纤溶酶原激活剂(tPA)在缺血性中风的治疗中用作溶栓剂,但对出血性转化的关注极大地限制了接受该治疗的患者数量。已经提出与溶栓性tPA相关的出血并发症可能是由于tPA在脑中的意外作用。最近的工作表明,tPA调节通过血小板衍生生长因子(PDGF)-C / PDGF受体-α(PDGFRα)信号传导介导的神经血管屏障完整性,这可能是影响中风预后的分子机制。为了更好地了解tPA在神经血管调节中的作用,我们对成年tPA缺陷(tPA〜(?/?))小鼠大脑中的脑血管进行了详细分析。我们的分析表明,tPA的终生缺陷与脑血管树的重排有关,包括与野生动物相比,血管平滑肌细胞覆盖的数量减少,直径大,血管减少以及与血管相关的PDGFRα表达减少类型(WT)同窝对照。此外,我们发现,tPA的切除导致ERG阳性内皮细胞数量增加和紧密连接蛋白ZO1的连接定位增加。这很有趣,因为ERG是一种涉及血管完整性调节的内皮转录因子。根据这些结果,我们认为利用这些tPA〜(β/β)小鼠看到的屏障特性的保护可能至少部分是由于这些脑血管的重排。此外,我们发现tPA〜(?/?)小鼠表现出轻度的脑室畸形,这以前与PDGF-C的消融有关,从而在中枢神经系统(CNS)发育中提供了tPA和PDGF信号之间的体内联系。 。综上所述,此处提供的数据将增进我们对tPA在中枢神经系统中的作用以及在调节脑血管通透性中的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号